Risultati della ricerca - L. Leoncini-Franscini
- Mostra 1 - 2 risultati su 2
-
1
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial di Verena Gotta, Nicolas Widmer, Laurent A. Décosterd, Yves Chalandon, Dominik Heim, Michael Gregor, Rudolf Benz, L. Leoncini-Franscini, Gabriela M. Baerlocher, Michel A. Duchosal, Chantal Csajka, Thierry Buclin
Pubblicazione 2014Artigo -
2
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the e... di Michele Ghielmini, Kaspar Rufibach, Gilles Salles, L. Leoncini-Franscini, Claire Falandry, Sergio Cogliatti, Martin F. Fey, Giovanni Martinelli, Rolf A. Stahel, Andreas Lohri, Nicolas Ketterer, Martin Wernli, Thomas Cerny, S.‐F. Hsu Schmitz
Pubblicazione 2005Artigo
Strumenti per la ricerca:
Soggetti correlati
Adverse effect
Internal medicine
Medicine
Surgery
Chemotherapy
Chronic myelogenous leukemia
Clinical endpoint
Clinical trial
Dosing
Follicular lymphoma
Gastroenterology
Imatinib
Imatinib mesylate
Immunology
Leukemia
Lymphocyte
Lymphoma
Mantle cell lymphoma
Myeloid leukemia
Neutropenia
Oncology
Pharmacokinetics
Randomized controlled trial
Rituximab
Tacrolimus
Therapeutic drug monitoring
Transplantation
Trough level